Literature DB >> 25559686

Examining perceived cancer risk among patients with neurofibromatosis type 1.

Elyse R Park1, Kelly B Smith, Vanessa L Merker, Alona Muzikansky, Ana-Maria Vranceanu, Daphne L Wang, Scott R Plotkin.   

Abstract

Neurofibromatosis 1 (NF1) is a genetic disorder in which patients are at significantly increased risk for developing malignant peripheral nerve sheath tumors (MPNST) and malignant gliomas (brain cancer). We sought to develop a measure for assessing perceived risk of developing MPNST and brain cancer among patients with NF1 and to examine patients' perceived risk of developing these cancers. We assessed 112 NF1 patients' perceived risk of developing MPNST and brain cancer using an 8-item scale we developed that yielded two subscales in a principal component analysis (PCA). Linear regression models examined factors associated with perceived risk of malignancy. 33.9 % and 47.3 % of patients disagreed that having NF1 placed them at increased risk for MPNST and brain cancer, respectively. The PCA of the perceived risk items yielded a 2-factor solution with an MPNST and a brain subscale (total scale α = 0.90). Level of anxiety was the primary factor associated with perceived risk for both cancers. A significant proportion of NF1 patients underestimate their risk of developing MPNST and brain cancer. Perceived risk was associated with emotional distress, in particular anxiety. Clinicians should actively communicate with NF1 patients about their elevated cancer risk.

Entities:  

Mesh:

Year:  2015        PMID: 25559686     DOI: 10.1007/s11060-014-1689-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

2.  Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income.

Authors:  Kesha J Buster; Zhiying You; Mona Fouad; Craig Elmets
Journal:  J Am Acad Dermatol       Date:  2011-08-27       Impact factor: 11.527

3.  Elevated risk for MPNST in NF1 microdeletion patients.

Authors:  T De Raedt; H Brems; P Wolkenstein; D Vidaud; S Pilotti; F Perrone; V Mautner; S Frahm; R Sciot; E Legius
Journal:  Am J Hum Genet       Date:  2003-03-26       Impact factor: 11.025

4.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

5.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

Authors:  J M Friedman; P H Birch
Journal:  Am J Med Genet       Date:  1997-05-16

6.  Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1).

Authors:  D H Gutmann; S A Rasmussen; P Wolkenstein; M M MacCollin; A Guha; P D Inskip; K N North; M Poyhonen; P H Birch; J M Friedman
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

Review 7.  Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis.

Authors:  Dejana Braithwaite; Jon Emery; Fiona Walter; A Toby Prevost; Stephen Sutton
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

8.  Underestimation of breast cancer risk: influence on screening behavior.

Authors:  Maria C Katapodi; Marylin J Dodd; Kathryn A Lee; Noreen C Facione
Journal:  Oncol Nurs Forum       Date:  2009-05       Impact factor: 2.172

9.  Perceived risk for gastric cancer among the general Korean population: a population-based survey.

Authors:  Min-Son Kwak; Kui Son Choi; Sohee Park; Eun-Cheol Park
Journal:  Psychooncology       Date:  2009-07       Impact factor: 3.894

10.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

View more
  1 in total

1.  Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.

Authors:  Dorinda Chee Yee Chew; Daniel Bin Hang Zhao; Kesavan Sittampalam; S Krishna Kumar
Journal:  J Radiol Case Rep       Date:  2020-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.